Beyond Ozempic: New GLP-1 drugs promise weight loss and …
网页June 23, 2024, 5:46 PM UTC. By Berkeley Lovelace Jr. The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo...
Many people using GLP-1s for weight loss stop treatment too soon ... - CNN
网页2024年5月21日 · An analysis of health insurance claims released Tuesday found that most people using GLP-1 medications – about 58% – were on their treatment plan for less than 12 weeks, falling short of a key...
More fiber in the diet may help boost levels of GLP-1, an Ozempic ... - NPR
网页2023年10月30日 · Popular weight-loss drugs mimic GLP-1, a hormone the body makes naturally after eating. Turns out some foods trigger GLP-1 better than others, making us feel full and eat less.
Weight-loss drugs like Wegovy may help stave off some cancers - NPR
网页2024年8月12日 · Several new studies find promising evidence that the GLP-1 class of drugs may have a cancer-preventive effect, especially for cancers linked to obesity.
FDA Approves First Treatment to Reduce Risk of Serious Heart …
网页The FDA approved a new use for a drug to reduce the risk of cardiovascular disease, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight.
Lasker awardee Svetlana Mojsov describes a yearlong journey out …
网页2 天之前 · After a whirlwind of new recognition for her GLP-1 research, the chemist has thoughts on allocating credit in science. Chemist Svetlana Mojsov made key discoveries involving the glucagon-like peptide-1 receptor in the 1980s. Lori Chertoff/Rockefeller University. The Lasker Awards, announced today, are among the …
FDA approves first oral GLP-1 treatment for type 2 diabetes
网页The U.S. Food and Drug Administration today approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise.
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
网页2 天之前 · 215.13 KB. The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.
Research shows GLP-1 drugs are effective but complex
网页2024年5月30日 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
MHRA approves GLP –1 receptor agonist semaglutide to reduce …
网页2024年7月23日 · This medicine, a GLP-1 receptor agonist, was already approved for use in the treatment of obesity and for weight management, to be used alongside diet, physical activity and behavioural support ...